{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:03:33Z","timestamp":1780041813655,"version":"3.53.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.msard.2025.106718","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:31:55Z","timestamp":1756855915000},"page":"106718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["When does multiple sclerosis start?"],"prefix":"10.1016","volume":"102","author":[{"given":"Gavin","family":"Giovannoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ann","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106718_bib0001","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2025.106718_bib0002","series-title":"Basic Biology to Clinical Manifestations","article-title":"Post-streptococcal autoimmune sequelae: rheumatic fever and beyond","author":"Cunningham","year":"2016"},{"key":"10.1016\/j.msard.2025.106718_bib0003","doi-asserted-by":"crossref","first-page":"s533","DOI":"10.2741\/1067","article-title":"Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease","volume":"8","author":"Cunningham","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.msard.2025.106718_bib0004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000521476","article-title":"Sickness and the social brain: how the immune system regulates behavior across species","volume":"97","author":"Devlin","year":"2022","journal-title":"Brain Behav. Evol."},{"key":"10.1016\/j.msard.2025.106718_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(17)30127-8","article-title":"The neurodegenerative prodrome in multiple sclerosis","volume":"16","author":"Giovannoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106718_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106337","article-title":"Infectious mononucleosis is a more realistic target for preventing multiple sclerosis","volume":"95","author":"Giovannoni","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106718_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaf170","article-title":"The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis","author":"Giovannoni","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106718_bib0008","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/qjmed\/hci135","article-title":"Are multiple sclerosis patients risk-takers?","volume":"98","author":"Hawkes","year":"2005","journal-title":"QJM."},{"key":"10.1016\/j.msard.2025.106718_bib0009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2013.05.002","article-title":"Risk associated behavior in premorbid multiple sclerosis: a case-control study","volume":"3","author":"Hawkes","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106718_bib0010","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992-1993 and 1993-1994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106718_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.887794","article-title":"The potential for EBV vaccines to prevent multiple sclerosis","volume":"13","author":"Maple","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106718_bib0012","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410260508","article-title":"The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord","volume":"26","author":"Miller","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106718_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2025.106718_bib0014","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106718_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein-Barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.msard.2025.106718_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.24635","article-title":"Health care use before multiple sclerosis symptom onset","volume":"8","author":"Ruiz-Alguer\u00f3","year":"2025","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.msard.2025.106718_bib0017","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424986122","article-title":"Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls","volume":"122","author":"Sattarnezhad","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.msard.2025.106718_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.msard.2025.106718_bib0019","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1038\/s41467-025-61751-9","article-title":"Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1-specific antibody titers","volume":"16","author":"Vietzen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2025.106718_bib0020","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/13524585251340812","article-title":"The path to prevention of multiple sclerosis: considerations for Epstein-Barr virus vaccine-based prevention studies","volume":"31","author":"Zane","year":"2025","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825004602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:22:56Z","timestamp":1780039376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825004602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"alternative-id":["S2211034825004602"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106718","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When does multiple sclerosis start?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106718"}}